Market Signal Briefing

, /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against V.F. Corporation ("VF " or "the Company") (NYSE: VFC ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Shareholders who purchased shares of VFC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments. Appointment as lead plaintiff is not required to partake in any recovery.

CLASS PERIOD: October 30, 2023 to May 20, 2025

DEADLINE: November 12, 2025

CASE DETAILS: According to the Complaint, the Company made false and misleading statements to the market. VF minimized the risk of seasonality and other risks in its communications to investors. The Company also claimed it could reliably forecast its revenue. In fact, the Company's positive outlook on revenue growth was not based on reliable data. Based on these facts, VF's public statements were false and materially misleading throughout the class period.

If you are a shareholder who suffered a loss, contact us to participate .

NEXT STEPS FOR SHAREHOLDERS : Once you register as a shareholder who purchased shares during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. There is no cost or obligation to you to participate in this case.

WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.

Join the case to recover your losses.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT: 
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]

SOURCE DJS Law Group LLP

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Draganfly Today

$8.14 +1.19 (+17.12%)

As of 04:00 PM Eastern

52-Week Range$1.63▼

$9.55Price Target$6.50

On Sept. 30, the market delivered a powerful and unambiguous verdict on Draganfly Inc. NASDAQ: DPRO. Shares of the drone technology company surged over 17%, driven by an unprecedented wave of investor interest that saw trading volume skyrocket to more than 58 million shares, a staggering figure compared to its daily average of roughly 1.9 million shares. This dramatic market action was ignited by a single, transformative catalyst: the announcement of a multifaceted contract with the U.S. Army.

For investors scrutinizing the company, this event signifies far more than a short-term price spike; it represents the culmination of a focused strategic pivot, potentially launching Draganfly into a new and far more stable phase of growth.

Get Draganfly alerts:

The Army Partnership: A Pillar of Growth
The agreement with the U.S. Army is significant not just for its prestige, but for its intelligent and deeply integrated structure. This contract provides Draganfly with more than a one-time hardware sale. It is a foundational partnership designed for long-term operational readiness, a distinction that fundamentally changes how investors should assess the company's future revenue potential and competitive standing.

More Than Drones: Strategic Depth
The contract's design reveals a forward-thinking approach that creates a durable and defensible relationship. It is built on three core pillars:

Advanced Technology: Draganfly will supply its high-performance Flex FPV (First Person View) drone systems. FPV technology, which gives operators a real-time, in-the-field view from the drone's perspective, has proven to be a game-changer for reconnaissance and tactical missions in modern conflicts, making it a high-priority capability for the U.S. military.
Embedded Manufacturing: As a key strategic differentiator, Draganfly will help establish on-site drone manufacturing within U.S. military facilities overseas. This innovative model is a logistical masterstroke, shortening critical supply chains, accelerating deployment, and embedding Draganfly's processes and technology directly into Army operations.
Training and Support: The company will also provide comprehensive flight and manufacturing training to Army personnel. This creates an ongoing service and support component, ensuring the U.S. Army can sustain its own drone operations and cementing Draganfly's role as an indispensable partner, not just a vendor.

From Plan to Partnership: A Proven Strategy
This landmark contract was the direct result of a series of deliberate strategic moves that validated Draganfly's technology and aligned the company with the stringent requirements of the Department of Defense (DoD). The company’s successful technology demonstrations at the T-REX 24-2 military exercise in September served as a crucial proof of concept.

The win was further enabled by Draganfly's proactive expansion of its U.S. manufacturing footprint and its steadfast focus on building a secure, NDAA-compliant supply chain, a non-negotiable prerequisite for sensitive defense contracts that immediately disqualifies many foreign-based competitors. The contract is the culmination of a clear pattern of execution by management, building on other key partnerships in the defense and humanitarian sectors, such as Draganfly’s work with SafeLane Global on demining drones.

Fuel for Growth: A Strong Balance Sheet
A major contract win can strain a smaller company's resources, but Draganfly's financial planning appears to have positioned it well to execute. While the company is still in its growth phase, it reported a net loss of $4.7 million in its second quarter 2025 earnings report; however, its balance sheet shows considerable strength.

At the end of Q2 2025, Draganfly's cash balance exceeded $22.5 million. This was further strengthened by a $25 million registered direct offering that was finalized in July. This capital base is critical, providing the necessary fuel to scale production and manage the complex logistics of the U.S. Army contract without the immediate need for dilutive financing. It allows the company to confidently fund its operations and bridge the gap toward what could be a significant and sustained increase in revenue.

A New Baseline for Draganfly’s Valuation
Draganfly Stock Forecast Today12-Month Stock Price Forecast:
$6.50
-20.15% Downside

Buy
Based on 2 Analyst Ratings

Current Price$8.14High Forecast$7.00Average Forecast$6.50Low Forecast$6.00Draganfly Stock Forecast Details

The partnership with the U.S. Army fundamentally alters the investment narrative for Draganfly. This contract serves as a powerful validation, effectively de-risking the company's technology and business model in the eyes of the market. It demonstrates a clear ability to move beyond smaller-scale programs and secure a cornerstone contract with one of the world's most demanding clients.

Consequently, prior analyst valuations and price targets, which currently form the consensus average of $6.50, are now based on outdated information. These figures were established before this transformative agreement was announced and are likely subject to upward revisions as financial models are updated to reflect this new reality. 

For investors, the conversation has shifted. The question is no longer whether Draganfly can win in the competitive defense sector but rather how effectively it can execute this foundational contract and leverage it to secure future growth. This U.S. Army deal establishes a new, and significantly higher, baseline for Draganfly’s trajectory and potential valuation.

Should You Invest $1,000 in Draganfly Right Now?Before you consider Draganfly, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Draganfly wasn't on the list.

While Draganfly currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

EON Resources Inc. (NYSE:EONR) Special Conference Call

Company Participants

Michael J. Porter - Investor Relations
Dante Caravaggio - President, CEO & Director
David M. Smith, Esq. - General Counsel
Mitchell Trotter - CFO, Senior VP & Director
Jesse Allen - Vice President of Operation
David Smith - VP, General Counsel & Secretary

Presentation

Operator

Good day, everyone, and welcome to the EON Resources, Inc. Special Conference Call discussion of $45.5 million funding and related Farmout Agreement. [Operator Instructions]. It is now my pleasure to turn the floor over to your host, Michael Porter. Sir, the floor is yours.

Michael J. Porter

Thank you, Matthew. Good afternoon, ladies and gentlemen, and welcome to our Special Conference Call. Before I turn the call over to management, I have to read the forward-looking statements.

This conference call includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involves risks and uncertainties that could cause actual results to differ materially from what is expected. Words such as expect, believe, anticipate, seek, might, plan, any variation in similar words and expressions are intended to identify such forward-looking statements. But in the absence of these words, it does not mean that a statement is not forward-looking. The company expectations are disclosed in the company's documents filed from time to time on EDGAR and with the Securities and Exchange Commission.

Without further ado, I'd like to turn the call over to Dante. Dante, the floor is yours.

Dante Caravaggio
President, CEO & Director

Thank you, Mike. Good afternoon, everybody. We're getting to be old friends. This is probably the seventh or eighth, one of these things we've done as a group. I apologize upfront because I'm in an airport, and we're going to get a little bit of background noise. So I'm on company overview slide. And all I'm going to highlight there is -- all

Recommended For You

SAXONBURG, Pa., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, proudly announced today that it has been recognized with two awards at ECOC 2025, Europe’s largest optical communications exhibition. The honors highlight Coherent’s commitment to driving breakthrough technologies that are enabling the next generation of high-performance, AI networks.

The following Coherent products were recognized for their innovation in their respective categories:

Optical Transport Award: Multi-Rail Resource Pooling System
An advanced optical amplification architecture that pools dynamic gain equalizers, channel monitors, and pump lasers across multiple transmission paths to boost C- and L-band throughput while cutting power, space, and hardware requirements.

Most Innovative Photonic Component Award: 400G Differential EML
The industry’s first 400G D-EML, offering >100 GHz bandwidth, low reflections, and reduced power consumption for cost-effective, scalable optical transceivers.

“We are honored to receive industry recognition at ECOC 2025, which reinforces Coherent’s position as a leader in optical innovation,” said Dr. Julie Eng, Chief Technology Officer at Coherent. “These achievements reflect the extraordinary expertise of our global teams and our ongoing commitment to deliver scalable, reliable, and energy-efficient technologies that power the future of communications.”

Coherent’s award-winning portfolio showcases the company’s unmatched breadth across materials, components, and systems. By driving innovation in optical communications, Coherent is helping customers address the unprecedented growth in datacenter, AI, and telecom networks.

About Coherent 

Coherent is the global photonics leader. We harness photons to drive innovation. Industry leaders in the datacenter, communications, and industrial markets rely on Coherent’s world-leading technology to fuel their own innovation and growth.

Founded in 1971 and operating in more than 20 countries, Coherent brings the industry’s broadest, deepest technology stack; unmatched supply chain resilience; and global scale to help its customers solve their toughest technology challenges. Visit us at coherent.com.

Media Contact: 
[email protected] 

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0978af78-9424-4253-af22-60bd6e7d0c01

Coherent honored at ECOC 2025
Coherent honored at ECOC 2025 with Industry Recognition for Optical Innovation

NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities (as well as purchasers of call options or sellers of put options) of Charter Communications, Inc. (NASDAQ: CHTR) between July 26, 2024 and July 24, 2025, both dates inclusive (the “Class Period”), of the important October 13, 2025 lead plaintiff deadline.

SO WHAT: If you purchased Charter Communications securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Charter Communications class action, go to https://rosenlegal.com/submit-form/?case_id=44682 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than October 13, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) the impact of the Federal Communications Commission’s (“FCC”) Affordable Connectivity Program (“ACP”) end was a material event the Company was unable to manage or promptly move beyond; (2) the ACP end was having a sustaining impact on Internet customer declines and revenue; (3) neither was Charter Communications executing broader operations in a way that would compensate for, or overcome the impact, of the ACP ending; (4) the Internet customer declines and broader failure of Charter’s execution strategy created much greater risks on business plans and earnings growth than reported; (5) accordingly, Charter Communications had no reasonable basis to state that it was successfully executing operations, managing causes of Internet customer declines, or provide overly optimistic statements about the long term trajectory of the Company and EBITDA growth; and (6) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements about Charter Communications’ business, operations, outlook during the Class Period. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Charter Communications class action, go to https://rosenlegal.com/submit-form/?case_id=44682 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Proceeds from the offering of senior unsecured notes, together with cash on hand, to be used to redeem $2.0 billion of 6.000% senior unsecured notes due 2029

, /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) today announced that Carnival Corporation (the "Company") priced its private offering (the "Notes Offering") of $1.25 billion aggregate principal amount of 5.125% senior unsecured notes due 2029 (the "Notes").

The Company expects to use the proceeds from the Notes Offering, together with cash on hand, to redeem its $2.0 billion 6.000% senior unsecured notes due 2029 (the "2029 Unsecured Notes") after the closing of the Notes Offering.

The transaction is a continuation of the Company's strategy to reduce interest expense. In addition, the indenture that will govern the Notes will have investment grade-style covenants.

The Notes Offering is expected to close on October 15, 2025, subject to customary closing conditions.

The Notes will pay interest semi-annually on May 1 and November 1 of each year, beginning on May 1, 2026 at a rate of 5.125% per year. The Notes will be unsecured and will mature on May 1, 2029. The Notes will be fully and unconditionally guaranteed on an unsecured basis, jointly and severally, by Carnival plc and certain of the Company's and Carnival plc's subsidiaries that also guarantee our first-priority secured indebtedness, certain of our other unsecured notes and our convertible notes.

This press release does not constitute a notice of redemption with respect to the 2029 Unsecured Notes.

The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and outside the United States, only to non-U.S. investors pursuant to Regulation S under the Securities Act.

The Notes will not be registered under the Securities Act or any state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.

This press release shall not constitute an offer to sell or the solicitation of an offer to purchase the Notes or any other securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offering, solicitation or sale would be unlawful.

About Carnival Corporation & plc

Carnival Corporation & plc is the largest global cruise company, and among the largest leisure travel companies, with a portfolio of world-class cruise lines - AIDA Cruises, Carnival Cruise Line, Costa Cruises, Cunard, Holland America Line, P&O Cruises, Princess Cruises and Seabourn.

Cautionary Note Concerning Forward-Looking Statements

Certain statements in this press release constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. These statements relate to, among other things, the financing transactions described herein, future results, operations, outlooks, plans, goals, reputation, cash flows and liquidity and other events which have not yet occurred. Forward-looking statements reflect management's current expectations and are subject to risks, uncertainties and other factors that could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Factors that could affect our results include, among others, those discussed under the caption "Risk Factors" in our most recent annual report on Form 10-K, as well as our other filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained by visiting the  Investor Relations page of our website at www.carnivalcorp.com/investors/ or the SEC's website at www.sec.gov. Undue reliance should not be placed on the forward-looking statements in this release, which are based on information available to us on the date hereof. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Carnival Corporation & plc

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

By Reuters

September 30, 20258:05 PM UTCUpdated ago

The logo for Occidental Petroleum is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 30, 2019. REUTERS/Brendan McDermid Purchase Licensing Rights, opens new tab

CompaniesSept 30 (Reuters) - Berkshire Hathaway is in talks to buy Occidental Petroleum's

(OXY.N), opens new tab petrochemical unit for about $10 billion, the Wall Street Journal reported on Tuesday citing people familiar with the matter.

Sign up here.

Reporting by Katha Kalia in Bengaluru; Editing by Tasim Zahid

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

MALMÖ, Sweden, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”) announced today that it has issued SEK denominated senior secured floating rate bonds in a total amount of SEK 1,700 million (the “Nordic Bonds”), entered into a new sustainability-linked SEK 750 million super senior revolving credit facility agreement and intends to complete its repurchase of certain U.S. Notes (as defined below).

Marie-José David, Oatly’s CFO, commented, “These transactions represent yet another step forward in our company’s transformation journey. They strengthen our financial foundation by reducing our total outstanding debt, lowering costs related to the remaining outstanding debt, improving the terms of our capital structure, as well as reducing the dilution impact of our convertible notes. We have done all this while not raising additional financing and our business plan remaining fully funded.”

The proceeds from the Nordic Bonds will initially fund into an escrow account and are intended to be released to the Company on or around October 3, 2025, subject to customary conditions. The new senior revolving credit facility is intended to become effective thereafter, subject to prepayment in full of the group’s existing $130 million term loan B credit facility (the “TLB”) and customary conditions. As previously communicated, the Company intends to use the net proceeds from the Nordic Bonds to prepay the TLB in full, to repurchase and cancel certain of its U.S. Notes as further described below and to pay related transaction costs.

The proceeds from the Nordic Bonds will also be used to complete the transactions contemplated by the Convertible Note Repurchase Agreements (the “Repurchase Agreements”) which the Company entered into on September 9, 2025, with certain accredited investors (the “Selling Noteholders”) that are holders of the Company’s 9.25% Convertible Senior PIK Notes due 2028 (CUSIP No. 67421J AC2) (the “U.S. Notes”). The transactions contemplated by the Repurchase Agreements will result in U.S. Notes sold by the Selling Noteholders being cancelled and no longer outstanding, and are expected to close on or around October 3, 2025, following release of the Nordic Bonds proceeds from escrow and prepayment of the TLB in full and subject to customary conditions.

Additional information regarding the foregoing transactions may be found in a Form 6-K that will be filed with the U.S. Securities and Exchange Commission.

This press release is neither an offer to sell nor a solicitation of an offer to buy any securities, nor shall it constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. There can be no assurances that the transactions will be completed as described herein or at all.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding our financial outlook for 2025, profitability improvement, profitable growth in 2025, long-term growth strategy, expected capital expenditures, anticipated returns on our investments, anticipated supply chain performance, anticipated impact of our improvement plans, anticipated impact of our decision to discontinue construction of certain production facilities, plans to achieve profitable growth and anticipated cost savings and efficiencies as well as statements that include the words “expect”, “intend”, “plan”, “believe”, “project”, “forecast”, “estimate”, “may”, “should”, “anticipate”, “will”, “aim”, “potential”, “continue”, “is/are likely to” and similar statements of a future or forward-looking nature. Forward-looking statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected, including, without limitation: our ability to consummate the transactions discussed herein on terms favorable to us or at all, our history of losses and how we may be unable to achieve or sustain profitability, including due to elevated inflation and increased costs for transportation, energy and materials; how our future business, financial condition and results of operations may be adversely affected by reduced or limited availability of oats and other raw materials and ingredients, which meet our quality standards, that our limited number of suppliers are able to sell us; how a failure to obtain necessary capital when needed on acceptable terms, or at all, may force us to delay, limit, reduce or terminate our product manufacturing and development and other operations; those concerning our cash and cash equivalents maintained at financial institutions, often in balances that exceed federally insured limits; any damage or disruption at our production facilities, which manufacture the primary components of all our products; harm to our brand or reputation due to real or perceived quality, food safety, nutrition or sustainability issues with our products, which could have an adverse effect on our business, reputation, financial condition and results of operations; food safety and food-borne illness incidents or other safety concerns that have led to product recalls and how such events may in the future materially adversely affect our business, financial condition and results of operations by exposing us to lawsuits or regulatory enforcement actions, increasing our operating costs and reducing demand for our product offerings; how a failure by our suppliers of raw materials or co-manufacturers to comply with food safety, environmental or other laws and regulations, or with the specifications and requirements of our products, may disrupt our supply of products and adversely affect our business; we may not be able to compete successfully in our highly competitive markets; risks from consolidation of customers or the loss of a significant customer; a reduction in sales of our oatmilk varieties, which contribute a significant portion of our revenue, would have an adverse effect on our business, financial condition and results of operations; relying heavily on our co-manufacturing partners; our strategic partnerships with co-manufacturers may not be successful, which could adversely affect our operations and manufacturing strategy; failure by our logistics providers to deliver our products on time, or at all, could result in lost sales; that we may not successfully ramp up operations at any of our facilities, or these facilities may not operate in accordance with our expectations; a failure to effectively expand our processing, manufacturing and production capacity through existing facilities, or a failure to find acceptable co-manufacturing or co-manufacturing partners to help us expand, as we continue to grow and scale our business to a steady operating level; failure to develop and maintain our brand; failure to develop or introduce new products or successfully improve existing products may adversely affect our ability to continue to grow; a failure to cost-effectively acquire new customers and consumers or retain our existing customers and consumers, or a failure to derive revenue from our existing customers consistent with our historical performance; consumer preferences for our products are difficult to predict and may change, and, if we are unable to respond quickly to new trends, our business may be adversely affected; a failure to manage our future growth effectively; impairment charges for long-lived assets and other exit costs in connection with our production facilities, and how we may need to recognize further costs in the future; sustainability risks (including environmental, climate change, uncertainty about future related mandatory disclosure requirements, and broader corporate social responsibility matters), which may materially adversely affect our business as a result of lawsuits, regulatory investigations and enforcement actions, complaints concerning our disclosures, impacts on our operations and supply chain (particularly in connection with the physical impacts of climate change), and impacts on our brand and reputation; reliance on information technology systems and how any inadequacy, failure or interruption of, or cybersecurity incidents affecting, those systems may harm our reputation and ability to effectively operate our business; how cybersecurity incidents or other technology disruptions could negatively impact our business and our relationships with customers; risks associated with how our customers generally are not obligated to continue purchasing products from us; difficulties as we expand our operations into countries in which we have no prior operating experience; risks associated with the international nature of our business; the successful execution of the strategic review of the Company’s Greater China operations, the outcome of the strategic review and the market reaction thereto; how our operations in China could expose us to substantial business, regulatory, political, financial and economic risks; our strategic reset in Asia may not be successful; if we fail to comply with trade compliance and economic sanctions laws and regulations of the United States, the EU and other applicable international jurisdictions, it could materially adversely affect our reputation and results of operations; packaging costs are volatile and may rise significantly; how fluctuations in our results of operations may impact, and may have a disproportionate effect on, our overall financial condition and results of operations; how litigation or legal proceedings could expose us to significant liabilities or costs and have a negative impact on our reputation or business; our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the market in which we compete achieves the forecasted growth, our business could fail to grow at similar rates, if at all; failure to retain our senior management or to attract, train and retain qualified employees; if we cannot maintain our company culture or focus on our mission as we grow, our success and our business and competitive position may be harmed; our insurance may not provide adequate levels of coverage against claims or we may be unable to find insurance with sufficient coverage at a reasonable cost; disruptions in the worldwide economy; macroeconomic conditions, including rising inflation, interest rates and supply chain constraints; global conflicts, other effects of ongoing wars and conflicts, and increasing geopolitical tensions and changes to international trade policies, treaties and tariffs, including as a result of the emergence of a trade war; the risk that legal claims, government investigations or other regulatory enforcement actions could subject us to civil and criminal penalties; how our operations are subject to U.S., EU, China and other laws and regulations, and there is no assurance that we will be in compliance with all regulations; changes in existing laws or regulations, or the adoption of new laws or regulations, may increase our costs and otherwise adversely affect our business, financial condition and results of operations; how we are subject to stringent environmental regulation and potentially subject to environmental litigation, proceedings and investigations; failure to protect our intellectual property, enforce or defend our intellectual property and other proprietary rights adequately, which may impact our commercial success; if we are unable to remediate material weaknesses, or if other material weaknesses are identified, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner; how our largest shareholder has significant influence over us, including significant influence over decisions that require the approval of shareholders; and the other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2024 filed with the U.S. Securities and Exchange Commission (“SEC”) on March 13, 2025 and our other filings with the SEC as such factors may be updated from time to time. Any forward-looking statements contained in this press release speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Oatly disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this press release, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

PARIS and CAMBRIDGE, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and announced its half year financial results for the six-month period ended June 30, 2025.

GIG HARBOR, Wash., Sept. 30, 2025 (GLOBE NEWSWIRE) -- California Water Service Group (NYSE: CWT) subsidiary Washington Water Service (Washington Water) has filed a request with the Washington Utilities and Transportation Commission (UTC) to increase water rates to recover $14.9 million in costs it has incurred to fund the improvement and maintenance of its local water systems as well as increased expenses over the last two years.

Some of the major investments made in Washington Water’s service areas include:

Installing 1,000 feet of water main in the Minterbrook system; 700 feet of main in Sunshine Acres; 2,500 feet of main in the Ranch Acres Shores system; 2,000 feet of main in Cedar Grove; 1,000 feet of main in Evergreen Shores; and 7,000 feet of main in the Southwood system to improve reliability and fire protection, and reduce potential leaks.Installing treatment facilities to remove lead and copper in the Heritage Row system, arsenic in the Quistorff system, and iron and manganese in the Southwood system.Conducting booster pump station upgrades in the Rosario, Cedar Crest, Artondale, Southwood, Olympic Mall, and Driftwood Valley systems.Deploying Supervisory Control and Data Acquisition remote system monitoring in the Sunshine Acres, Rosario, Mirrormont, Palmer Lake, and Southwood systems.Installing a new booster pumping facility to increase reliability and capacity in the Lost Creek zone of the Southwood system. Additionally, the proposed water rate increase accounts for costs incurred due to higher operating expenses, such as cost increases in materials and equipment; depreciation expense due to the addition of newly installed facilities; and increased labor costs. It also accounts for costs incurred for testing for the presence of per- and polyfluoroalkyl substances (PFAS) in accordance with new federal regulations, and other efforts related to PFAS regulatory compliance.

“We take our responsibility to provide our Washington Water customers safe, clean, reliable water at affordable rates seriously, and the upgrades we have made over the past two years are critical to continuing to deliver on this commitment,” said Marty Kropelnicki, Chairman and CEO. “At the same time, we work diligently to control expenses and keep water service affordable in the face of increasingly stringent federal and state water quality standards and rising costs.”

If approved as filed, new rates could become effective as early as Nov. 15, 2025.

About California Water Service Group

California Water Service Group (NYSE: CWT) is the largest regulated water utility operating exclusively in the western United States. It provides high-quality, reliable water and/or wastewater services to more than 2.1 million people in California, Hawaii, New Mexico, Washington, and Texas through its regulated subsidiaries, California Water Service, Hawaii Water Service, New Mexico Water Service, and Washington Water Service, and its utility holding company, Texas Water Service. 

Group’s purpose is to enhance the quality of life for customers, communities, employees, and stockholders. To do so, it invests responsibly in water and wastewater infrastructure, sustainability initiatives, and community well-being. The company’s nearly 1,300 employees live by a set of strong core values and share a commitment to protecting the planet, caring for people, and operating with the utmost integrity. The company has been named one of “America’s Most Responsible Companies” and one of the “World’s Most Trustworthy Companies” by Newsweek, a USA Top Workplace, and a Great Place to Work®. More information is available at www.calwatergroup.com.

This news release contains forward-looking statements within the meaning established by the Private Securities Litigation Reform Act of 1995 ("PSLRA"). The forward-looking statements are intended to qualify under provisions of the federal securities laws for "safe harbor" treatment established by the PSLRA. Forward-looking statements in this news release are based on currently available information, expectations, estimates, assumptions and projections, and our management's beliefs, assumptions, judgments and expectations about us, the water utility industry and general economic conditions. These statements are not statements of historical fact. When used in our documents, statements that are not historical in nature, including words like will, would, expects, intends, plans, believes, may, could, estimates, assumes, anticipates, projects, progress, predicts, hopes, targets, forecasts, should, seeks or variations of these words or similar expressions are intended to identify forward-looking statements. Examples of forward-looking statements in this news release include, but are not limited to, statements describing Washington Water's request to increase water rates and, if approved, the potential timing for such rates to become effective. Forward-looking statements are not guarantees of future performance. They are based on numerous assumptions that we believe are reasonable, but they are open to a wide range of uncertainties and business risks. Consequently, actual results or outcomes may vary materially from what is contained in a forward-looking statement. Factors that may cause actual results or outcomes to be different than those expected or anticipated include, but are not limited to those described under the section entitled "Risk Factors" and elsewhere in our most recent Annual Report on Form 10-K, our subsequent Quarterly Reports on Form 10-Q and our other Securities and Exchange Commission filings. In light of these risks, uncertainties and assumptions, investors are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. We are not under any obligation, and we expressly disclaim any obligation to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.

Media Contact
Yvonne Kingman
[email protected]
310-257-1434

September 30, 2025 16:15 ET

 | Source:

American Assets Trust, Inc.

SAN DIEGO, Sept. 30, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its third quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, October 28, 2025.

Senior management will hold a conference call for its third quarter 2025 earnings on Wednesday, October 29, 2025 at 8:00 a.m. Pacific Time (“PT”).

To access the conference call, please dial 1 (833) 816-1162 and ask to join the American Assets Trust, Inc. Conference Call.

A live on-demand audio webcast of the conference call will be available on the “Investor Relations” section of the Company’s website at www.americanassetstrust.com. A replay webcast will be available on the Company’s website approximately one hour after the conclusion of the conference call.

About American Assets Trust, Inc.

American Assets Trust, Inc. is a full service, vertically integrated and self-administered real estate investment trust (“REIT”), headquartered in San Diego, California. The company has over 55 years of experience in acquiring, improving, developing and managing premier office, retail, and residential properties throughout the United States in some of the nation’s most dynamic, high-barrier-to-entry markets primarily in Southern California, Northern California, Washington, Oregon, Texas and Hawaii. The company's office portfolio comprises approximately 4.3 million rentable square feet, and its retail portfolio comprises approximately 2.4 million rentable square feet. In addition, the company owns one mixed-use property (including approximately 94,000 rentable square feet of retail space and a 369-room all-suite hotel) and 2,302 multifamily units. In 2011, the company was formed to succeed to the real estate business of American Assets, Inc., a privately held corporation founded in 1967 and, as such, has significant experience, long-standing relationships and extensive knowledge of its core markets, submarkets and asset classes. For additional information, please visit www.americanassetstrust.com.

Forward Looking Statements

This press release may contain forward-looking statements within the meaning of the federal securities laws, which are based on current expectations, forecasts and assumptions that involve risks and uncertainties that could cause actual outcomes and results to differ materially. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” or “potential” or the negative of these words and phrases or similar words or phrases which are predictions of or indicate future events or trends and which do not relate solely to historical matters. The following factors, among others, could cause actual results and future events to differ materially from those set forth or contemplated in the forward-looking statements: adverse economic or real estate developments in our markets; defaults on, early terminations of or non-renewal of leases by tenants, including significant tenants; decreased rental rates or increased vacancy rates; our failure to generate sufficient cash flows to service our outstanding indebtedness; fluctuations in interest rates and increased operating costs; our failure to obtain necessary outside financing; our inability to develop or redevelop our properties due to market conditions; investment returns from our developed properties may be less than anticipated; general economic conditions, including the impact of tariffs and other trade restrictions; financial market fluctuations; risks that affect the general office, retail, multifamily and mixed-use environment; the competitive environment in which we operate; system failures or security incidents through cyberattacks; the impact of epidemics, pandemics, or other outbreaks of illness, disease or virus and the actions taken by government authorities and others related thereto, including the ability of our company, our properties and our tenants to operate; difficulties in identifying properties to acquire and completing acquisitions; our failure to successfully operate acquired properties and operations; risks related to joint venture arrangements; potential litigation; difficulties in completing dispositions; conflicts of interests with our officers or directors; lack or insufficient amounts of insurance; environmental uncertainties and risks related to adverse weather conditions and natural disasters; other factors affecting the real estate industry generally; limitations imposed on our business and our ability to satisfy complex rules in order for American Assets Trust, Inc. to continue to qualify as a REIT, for U.S. federal income tax purposes; and changes in governmental regulations or interpretations thereof, such as real estate and zoning laws and increases in real property tax rates and taxation of REITs. While forward-looking statements reflect the company's good faith beliefs, assumptions and expectations, they are not guarantees of future performance. For a further discussion of these and other factors that could cause the company's future results to differ materially from any forward-looking statements, see the section entitled “Risk Factors” in the company's most recent annual report on Form 10-K, and other risks described in documents subsequently filed by the company from time to time with the Securities and Exchange Commission. The company disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, of new information, data or methods, future events or other changes.

Source: American Assets Trust, Inc.

Investor Contact:
American Assets Trust
Robert F. Barton
Executive Vice President and Chief Financial Officer
858-350-2607

, /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2025 on Thursday, October 30, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour. 

The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 1-800-836-8184 within the U.S. or +1 646-357-8785 outside the U.S. a few minutes before 2:00 PM PT and referencing Conference ID #95263.

Envista's earnings press release, the webcast slides, and other related presentation materials will be posted to the "Investors" section of Envista's website before the conference call and will remain available following the call.

ABOUT ENVISTA HOLDINGS CORPORATION

Envista is a global family of more than 30 trusted dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by a shared purpose: to partner with professionals to improve lives. Envista helps its customers deliver the best possible patient care through industry-leading dental consumables, solutions, technology, and services. Its comprehensive portfolio, including dental implants and treatment options, orthodontics, and digital imaging technologies, covers a wide range of dentists' clinical needs for diagnosing, treating, and preventing dental conditions as well as improving the aesthetics of the human smile. With a foundation comprised of the proven Envista Business System (EBS) methodology, an experienced leadership team, and a strong culture grounded in continuous improvement, commitment to innovation, and deep customer focus, Envista is well equipped to meet the end-to-end needs of dental professionals worldwide. Envista is one of the largest global dental products companies, with significant market positions in some of the most attractive segments of the dental products industry. For more information, please visit www.envistaco.com.

FOR FURTHER INFORMATION
Jim Gustafson
Vice President, Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
[email protected] 

SOURCE Envista Holdings Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

, /PRNewswire/ -- Simon Griffiths, President and Chief Executive Officer of Camden National Corporation (NASDAQ: CAC; the "Company"), announced today that the board of directors of the Company declared a quarterly dividend of $0.42 per share. This quarterly payout results in an annualized dividend yield of 4.34% based on the September 29, 2025 closing price of the Company's common stock at $38.72 per share as reported by NASDAQ. The dividend is payable on October 31, 2025, to shareholders of record at the close of business on October 15, 2025.

About Camden National Corporation

Camden National Corporation (NASDAQ: CAC) is Northern New England's largest publicly traded bank holding company, with approximately $6.9 billion in assets. Founded in 1875, Camden National Bank has 72 banking centers in Maine and New Hampshire and is a full-service community bank offering the latest digital banking, complemented by award-winning, personalized service. Additional information is available at CamdenNational.bank. Member FDIC. Equal Housing Lender.

Comprehensive wealth management, investment, and financial planning services are delivered by Camden National Wealth Management.

SOURCE Camden National Corporation

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

Ad hoc announcement pursuant to Art. 53 LR

Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering unique approach to CSU treatment1Well-controlled disease observed as fast as two weeks, with demonstrated safety profile that requires no lab monitoring1   1.7 million people in US live with CSU; more than half remain symptomatic despite increasing doses of antihistamines2,3Remibrutinib also in clinical development for chronic inducible urticaria, food allergy, and hidradenitis suppurativa, expanding Novartis Immunology portfolio
Basel, September 30, 2025 – Novartis announced today that Rhapsido® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult patients with chronic spontaneous urticaria (CSU) who remain symptomatic despite H1 antihistamine treatment. Rhapsido is a pill taken twice daily and does not require injections or lab monitoring. It is the first FDA-approved Bruton’s tyrosine kinase inhibitor (BTKi) for CSU. Rhapsido helps to inhibit the release of histamine and other proinflammatory mediators by targeting BTK, offering a unique approach to CSU treatment.1  

“CSU is a serious disease that can cause debilitating symptoms and unpredictable flares. It’s difficult to diagnose and manage,” said Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and member of the steering committee for the remibrutinib REMIX Phase III clinical trial program. “Remibrutinib represents a new way of treating CSU. By blocking the activity of BTK, remibrutinib stops a key pathway of the immune response in CSU. This is an exciting new option that has the potential to help a broad range of patients get fast relief.”

CSU is a mast cell-driven condition thought to be caused by immune dysregulation. In people with CSU, the immune system can become activated through allergic (IgE) or autoimmune (IgG) pathways.4 This causes certain immune cells—mast cells and basophils—to activate the BTK protein. While not fully understood, it is believed that once activated, BTK leads to the release of histamine and other proinflammatory mediators that may cause the red, swollen, and itchy hives commonly seen in CSU.5,6

CSU symptoms are unpredictable, recurring for six weeks or more without an identified cause.7 Diagnosis can take up to 24 months.8 Many CSU patients say their symptoms negatively impact their sleep, work, and mental health.9,10,11 Antihistamines are the first-line treatment, but over half of patients still have symptoms, even at higher doses.2 Injectable treatments exist for those who don't respond to antihistamines, yet fewer than 20% of eligible patients receive them.12

“The approval of remibrutinib is an important development in CSU care. It quickly reduces symptoms, offering patients control of the hives and itching that they experience on a daily basis,” said Giselle Mosnaim, MD, MS, an Allergist and Immunologist from Endeavor Health, Clinical Associate Professor at the University of Chicago Pritzker School of Medicine and REMIX trial investigator. “This is significant because it expands beyond existing injectable treatments and gives patients an oral option that can easily be incorporated into their daily lives.”

“Many CSU patients feel misunderstood and settle for treatments that don’t fully meet their needs,” said Lynda Mitchell, CEO of Allergy & Asthma Network. “We support new treatment options that empower patients to choose what works best for them. This convenient new oral therapy offers a promising new way to manage CSU and potentially improve daily life for those living with this challenging condition.”

Clinical data supporting approval
The FDA approval of Rhapsido in CSU is based on results from the Phase III REMIX-1 (NCT05030311) and REMIX-2 (NCT05032157) clinical trials in patients who remained symptomatic on second-generation H1 antihistamines. Rhapsido demonstrated superiority in change from baseline versus placebo in itch (ISS7), hives (HSS7), and weekly urticaria activity (UAS7) at Week 12.13 Significantly more patients treated with Rhapsido versus placebo achieved well-controlled disease (UAS7≤6) as early as Week 2 and at Week 12, and about one-third of patients achieved complete absence of itch and hives at Week 12.13 Rhapsido has a demonstrated safety profile that requires no lab monitoring.13 The most common adverse events (incidence ≥3%) were nasal congestion, sore throat, and runny nose (nasopharyngitis), bleeding, headache, nausea, and abdominal pain.13

Novartis has completed regulatory submissions for Rhapsido for the treatment of CSU across many countries, including in the European Union, Japan, and China, with priority review granted in China. 

Transforming care in Immunology
“This approval of Rhapsido as the first and only BTK inhibitor in CSU is an important milestone in our journey to reshape care for overlooked immune-related conditions and offer more patients the potential to find fast relief,” said Victor Bultó, President, US, Novartis. “Building on our legacy in advancing the treatment of allergic, dermatologic, and rheumatologic conditions, we are deeply committed to further investing in innovative, patient-focused therapies across immunology.”

Discovered and developed by Novartis to target the BTK pathway as a driver of inflammation, remibrutinib is being investigated in ongoing clinical trials across a variety of immune-related conditions, including chronic inducible urticaria (CIndU), hidradenitis suppurativa (HS), and food allergy.

Disclaimer
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as “potential,” “can,” “will,” “plan,” “may,” “could,” “would,” “expect,” “anticipate,” “look forward,” “believe,” “committed,” “investigational,” “pipeline,” “launch,” or similar terms, or by express or implied discussions regarding potential marketing approvals, new indications or labeling for the investigational or approved products described in this press release, or regarding potential future revenues from such products. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events, and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There can be no guarantee that the investigational or approved products described in this press release will be submitted or approved for sale or for any additional indications or labeling in any market, or at any particular time. Nor can there be any guarantee that such products will be commercially successful in the future. In particular, our expectations regarding such products could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; the particular prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors referred to in Novartis AG’s current Form 20-F on file with the US Securities and Exchange Commission. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide.

Reimagine medicine with us: Visit us at https://www.novartis.com and connect with us on LinkedIn, Facebook, X/Twitter and Instagram.

References

Rhapsido® (remibrutinib) Prescribing Information. Novartis Pharmaceuticals Corp. Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA²LEN task force report. Allergy. 2011;66:317-330. doi:10.1111/j.1398-9995.2010.02496.xThe World Bank. Population, total. Accessed June 2025. https://data.worldbank.org/indicator/SP.POP.TOTLKolkhir P, Muñoz M, Asero R, et al. Autoimmune chronic spontaneous urticaria. J Allergy Clin Immunol. 2022;149(6):1819-1831. doi:10.1016/j.jaci.2022.04.010Kolkhir, P., Giménez-Arnau, A.M., Kulthanan, K. et al. Urticaria. Nat Rev Dis Primers. 8, 61 (2022). https://doi.org/10.1038/s41572-022-00389-zMendes-Bastos P, Brasileiro A, Kolkhir P, et al. Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions. Allergy. 2022;77(8):2355-2366.Maurer M, Costa C, Gimenez Arnau A, et al. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin Exp Allergy. 2020;50:1166-1175. doi: 10.1111/cea.13716Friedman A, Kwatra SG, Yosipovitch G. A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria. Dermatol Ther (Heidelb). 2024;14(6):1371-1387. doi: 10.1007/s13555-024-01173-5Mendelson M, Bernstein J, Gabriel S, et al. Patient-reported impact of chronic urticaria compared with psoriasis in the United States. J Dermatolog Treat. 2017; 28(3):229-236. doi:10.1080/09546634.2016.1227421 Maurer M, Abuzakouk M, Bérard F, et al. The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU. Allergy. 2017;72(12):2005-2016. doi:10.1111/all.13209Balp M-M, Krupsky K, Balkaran BL, et al. Oral presentation at: European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2023; June 9–11, 2023; Hamburg, Germany.Maurer M, Raap U, Staubach P, et al. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study. Clin Exp Allergy.2019; 49: 655–662. https://doi.org/10.1111/cea.13309Metz M, Giménez-Arnau A, Hide M, et al. Long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria in the Phase 3 REMIX-1 and REMIX-2 studies. Presented as a late oral abstract session on clinical trials at EAACI 2024; May 31-June 3, 2024; Valencia, Spain.
Novartis Media Relations
E-mail: [email protected]       Novartis Investor Relations
Central investor relations line: +41 61 324 7944
E-mail: [email protected]   9/25        UPR        FA-11459252

September 30, 2025 4:15 PM EDT | Source: Micromem Technologies Inc.
Toronto, Ontario and New York, New York,--(Newsfile Corp. - September 30, 2025) - Micromem Technologies Inc. (CSE: MRM) (OTCQB: MMTIF) ("Micromem" or the "Company") announces the intention to proceed with a non-brokered private placement (the "Private Placement") by placing common share units at a price of CAD $0.055 per unit (a "Unit") for a total of up to CAD $400,000, subject to a 50% discretionary increase. Each Unit is comprised of one common share and one warrant exercisable at CAD $0.06 per share for a period of one year. Micromem intends to use the proceeds raised through the Private Placement for working capital purposes and debt settlement. All securities to be issued pursuant to the Private Placement will be subject to a four-month hold period. The Private Placement remains subject to final regulatory approvals.

The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933 or any state securities laws, and accordingly, may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons except in compliance with the registration requirements of the U.S. Securities Act of 1993 and applicable state securities laws or pursuant to exemptions there from. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities in any jurisdiction.

About Micromem.

Micromem Technologies Inc. and its subsidiaries, a publicly traded (OTCQB: MMTIF) (CSE: MRM) company analyzes specific industry sectors to create intelligent game-changing applications that address unmet market needs. By leveraging its expertise and experience with sophisticated sensor applications, the Company successfully powers the development and implementation of innovative solutions for oil & gas, utilities, automotive, healthcare, government, information technology, manufacturing and other industries. Visit www.micromeminc.com.

Safe Harbor Statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; continued consumer adoption of digital technology; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer and technological demands; inability to replace significant customers; seasonal nature of our business; and other risks detailed in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements.

The CSE or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management.

###

Listing: OTCQB - Symbol: MMTIF
CSE - Symbol: MRM
Shares issued:607,024,014
SEC File No: 0-26005

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268578

, /PRNewswire/ -- ONE Gas, Inc. (NYSE: OGS) will release its third quarter 2025 financial results after the market closes on Monday, November 3, 2025.

The ONE Gas executive management team will participate in a conference call the following day, Tuesday, November 4, 2025, at 11 a.m. Eastern Standard Time (10 a.m. Central Standard Time).

The call will also be carried live on the ONE Gas website.

Event:

ONE Gas third quarter 2025 earnings conference call and webcast

Date and Time:

November 4, 2025

11 a.m. Eastern, 10 a.m. Central

Phone Number:

Dial 833-470-1428, pass code 020289

Webcast Access:

www.onegas.com/investors and select Events and Presentations

If you are unable to participate in the conference call or the webcast, the replay will be available on the ONE Gas website, www.onegas.com, for 30 days. A recording will be available by phone for seven days. The playback call may be accessed at 866-813-9403, pass code 909340.

ONE Gas, Inc. (NYSE: OGS) is a 100-percent regulated natural gas utility, and trades on the New York Stock Exchange under the symbol "OGS." ONE Gas is included in the S&P MidCap 400 Index and is one of the largest natural gas utilities in the United States.

Headquartered in Tulsa, Oklahoma, ONE Gas provides a reliable and affordable energy choice to more than 2.3 million customers in Kansas, Oklahoma and Texas. Its divisions include Kansas Gas Service, the largest natural gas distributor in Kansas; Oklahoma Natural Gas, the largest in Oklahoma; and Texas Gas Service, the third largest in Texas, in terms of customers.

For more information and the latest news about ONE Gas, visit onegas.com and follow its social channels: @ONEGas, Facebook, LinkedIn and YouTube. 

Analyst Contact:

Erin Dailey

918-947-7411

Media Contact:

Leah Harper

918-947-7123

SOURCE ONE Gas, Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+

Newsrooms &

Influencers

9k+

Digital Media

Outlets

270k+

Journalists

Opted In

September 30, 2025 16:17 ET

 | Source:

Vow ASA

Oslo, 30 September 2025: Reference is made to note 5 in Vow ASA's (the "Company") interim report for H1/Q2 2025 and the cautionary note regarding the risk that the Company will be in breach of its rolling 12-month NIBD/EBITDA ratio covenant requirements for the next quarters, and that the Company is in close and constructive dialog with DNB in this respect.

The Company has today obtained a formal waiver from DNB for the reporting period ending on 30 September 2025.

For more information, please contact:
Cecilie Brænd Hekneby, CFO, Vow ASA
Tel: +47 992 93 826
Email: [email protected]

About Vow
Vow and its subsidiaries Scanship, C.H. Evensen and Etia are passionate about preventing pollution. The company's world leading solutions convert biomass and waste into valuable resources and generate clean energy for a wide range of industries.

Advanced technologies and solutions from Vow enable industry decarbonisation and material recovery. Biomass, sewage sludge, plastic waste and end-of-life tyres can be converted into clean energy, low carbon fuels and renewable carbon that replace natural gas, petroleum products and fossil carbon. The solutions are scalable, standardised, patented, and thoroughly documented, and the company's capability to deliver is well proven.

The company is a cruise market leader in wastewater purification and valorisation of waste. It provides technology and solutions which enable industries to transition towards a fossil-free future by converting biomass and waste into valuable resources and clean energy. The company also has strong niche positions in food safety and robotics, and in heat-intensive industries with a strong decarbonising agenda.

Located in Oslo, the parent company Vow ASA is listed on the Oslo Stock Exchange (ticker VOW).

Chainlink announced today at SIBOS 2025 a technological solution that will give financial institutions worldwide control over digital asset operations using SWIFT messaging. Swift messages, CRE, and banks will access blockchains through the same Swift infrastructure they have relied upon for decades.

According to Chainlink, financial institutions will be able to handle tokenized fund subscription and redemption processes using Swift via ISO 20022 messages from their existing systems. The innovation powered by the Chainlink Runtime Environment (CRE)  will eliminate a technical barrier to the widespread adoption of digital assets in the international capital market.

Chainlink uses Swift to power tokenized fund transactions

MAJOR NEWS:

Chainlink announced today a landmark technical solution enabling financial institutions worldwide to manage digital asset workflows directly from their existing systems using Swift messaging and CRE, in collaboration with UBS ↓ pic.twitter.com/X6BcUKEjTi

— Chainlink Everything (@SmartContract) September 30, 2025

Chainlink stated that it has developed a technical process enabling banks to interact with tokenized investment funds through SWIFT.  The blockchain data provider noted that the first use case involved a technical and operational pilot with UBS Tokenize, building on prior work with the Monetary Authority of Singapore.

Sergey Nazarov, Chainlink co-founder, stated that the solution utilizes CRE, in conjunction with the Swift financial messaging network, to trigger subscription and redemption workflows for tokenized funds. He added that institutions will not replace their legacy systems or build new identity and key management layers. Nazarov stressed that CRE receives ISO 20022-compliant SWIFT messages, which in turn activate smart contract events in the Oracle protocol Digital Transfer Agent (DTA) technical standard.

“I’m very excited about this landmark innovation we’ve achieved by leveraging Swift’s standards and UBS’ tokenized asset design.”

–Sergey Nazarov– Chainlink co-founder.

Nazarov emphasized that UBS demonstrates how smart contract-based technologies enable financial institutions to explore enhanced composability of product lifecycles.

Chainlink stated that the ability to interact with complex on-chain workflows through Swift messaging is a groundbreaking development, reducing operational friction and delivering efficiency gains through programmable infrastructure.  The Decentralized Oracle Network has revealed that it is positioning the integration as a “plug-and-play” unlock for the $100 trillion-plus global financial industry.

According to the blockchain middleware provider,  Swift’s financial messaging services link more than 11,000 institutions in more than 200 countries and serve as the backbone of the infrastructure that facilitates trillions of dollars’ worth of cross-border payments. 

Chainlink expands Blockchain pilots with Swift and global banks
Chainlink announced on Monday at SIBOS that it had completed the second phase of a blockchain and AI-driven pilot for processing corporate actions.  The Blockchain middleware provider added that the initiative coordinated multiple large language models, including OpenAI’s GPT, Google’s Gemini, and Anthropic’s Claude, to generate structured, ISO 20022-compliant records transmitted through Swift’s network. Major players, including DTCC, Euroclear, and banks such as UBS, DBS, and BNP Paribas, backed the effort.

At SIBOS 2016, Chainlink co-founder Sergey Nazaro described an automated, innovative contract-based solution for the post-trade securities lifecycle, specifically ISO 20022-compliant bond instruments.  

The announcement also revealed that, as part of the Monetary Authority of Singapore (MAS, UBS Asset Management, and the decentralized oracle network successfully demonstrated how the combination of fintech infrastructure enabled automated fund management operations and transfer agency processes. 

Visa highlighted in a report released in June 2025 that ANZ Bank and Chainlink are participants in phase 2 of the Hong Kong Monetary Authority’s e-HKD pilot program. The report emphasized that participants employed a Payment-vs-Payment (PvP) settlement workflow utilizing an Australian Stablecoin (A$DC) on ANZ’s DAS Chain on Ethereum Sepolia. The PVP used the Web3 infrastructure provider for cross-chain connectivity and compliance verification. 

According to the Visa report, the next phase will demonstrate a Delivery vs. Payment (DvP) workflow involving an Australian investor purchasing a tokenized asset in Hong Kong. The phase will leverage cross-chain connectivity, Nav pricing, and the Oracle protocol’s Digital Transfer Agent technical standards. 

Jonathan Ehrenfeld Solé, Head of Strategy at Swift, stated that the solution leveraged Oracle infrastructure to feed external interest rate data into a smart contract. 

“That was maybe the first steps of this sort of love story between Swift and Chainlink, which continues today.”

Jonathan Ehrenfeld Solé– Head of Strategy at Swift

At Sibos 2024, Sergey Nazarov introduced a pre-production solution that enabled banks to connect to blockchains using the Swift messaging standards and infrastructure already used in traditional financial systems.

Join a premium crypto trading community free for 30 days - normally $100/mo.

Circle Internet Group is exploring mechanisms to allow transactions in its USDC stablecoin to be reversed in cases of fraud or disputes, according to a Financial Times report.

In an interview reported by FT, Circle President Heath Tarbert said the company is “thinking through … whether or not there’s the possibility of reversibility of transactions.” He added that enabling refunds in fraud cases, similar to traditional finance, could help bring stablecoins into broader mainstream use.

Tarbert also acknowledged a tension between refundability and irreversible settlement. He said that while the company seeks a system with final settlement, the concept of reversibility introduces a conflict with the ideally immediate and irrevocable nature of blockchain transfers.

Circle is the issuer of USDC, the second‑largest stablecoin by market capitalization, following Tether’s USDT. In 2025, Circle went public through an initial public offering, marking one of the sector’s highest‑profile moves into the public markets.

As of now, Circle has not publicly confirmed detailed designs or timelines for any reversibility mechanism

Chainlink price has attracted fresh attention after recent analyst insights highlighted key technical patterns. The expert emphasized how LINK price is aligning with broader market structure, suggesting a possible continuation of its upward trajectory. Meanwhile, institutional activity around tokenization is also placing the spotlight back on Chainlink’s role in shaping future financial infrastructure. 

Chainlink Price Holds Key Support As Analyst Targets $47
Specifically, an analyst, Ali, highlights how the Chainlink price has been moving within a defined ascending channel, repeatedly bouncing from the lower boundary and retesting upper resistance. 

His perspective emphasizes that if LINK price maintains the $20 level, the path toward higher zones could remain intact, creating room for a sharp continuation. The expert believes this cycle mirrors earlier expansions, where defended supports opened the door for rapid rallies. 

Notably, Ali points out that the technical script rarely changes, even though market reactions appear dramatic. The current Chainlink market price trades at $21.28, and such positioning keeps the token well within the channel’s bullish structure. Meanwhile, Ali stresses that sustained support could form the foundation for larger moves, with $47 emerging as the next key upside target.

LINK/USDT 3-Day Chart (Source: X)
On the 4-hour chart, LINK displays an inverse head-and-shoulders formation, widely recognized as a reversal trigger in technical analysis. The neckline breakout sits near $22, and clearing it could quickly propel LINK toward $24.69 and $25.64. 

Specifically, this shorter timeframe structure reinforces the daily channel outlook, suggesting alignment between intraday and broader patterns. The current consolidation near $21 reflects that buyers are absorbing sell pressure and defending key support areas. 

Moreover, whales recently scooped up 800K LINK from the demand zone, showing confidence in the asset’s recovery potential. With this backdrop, the expert’s $47 projection gains added relevance, while the broader technical picture continues to validate a sustained long-term Chainlink price prediction that extends well beyond immediate upside targets.

LINK/USDT 4-Hour Chart (Source: TradingView)
Tokenization With DTA Standard: UBS Adoption Strengthens Chainlink’s Case
Beyond technicals, Chainlink’s institutional integrations are adding crucial weight. UBS Asset Management, through its in-house tokenization unit UBS Tokenize, is adopting the Chainlink Digital Transfer Agent (DTA) standard. 

This framework streamlines fund workflows, including subscriptions, redemptions, and settlement processes. The inclusion of support for fiat and digital assets makes it highly versatile. Additionally, automated compliance features align operations with regulatory frameworks, ensuring security and efficiency.

Meanwhile, the DTA standard also leverages Chainlink’s Cross-Chain Interoperability Protocol (CCIP), allowing secure multi-chain transfers. NAVLink feeds enhance valuation accuracy, ensuring transparent pricing for tokenized assets. 

Together, these features reduce friction in fund lifecycle management, making Chainlink indispensable for institutional adoption. Notably, the DTA standard positions LINK at the center of the $100 trillion fund industry’s gradual shift to tokenization.

Furthermore, Chainlink’s ecosystem strength is amplified by fresh integrations, with Polymarket partnering with Chainlink to boost its market resolution process, signaling broader real-world adoption of its infrastructure.

To conclude, Chainlink price continues to show resilience as both charts and fundamentals reinforce the bullish outlook. LINK price remains supported by structural patterns and institutional integrations. With tokenization progress and technical setups converging, the narrative remains decisive. Chainlink is now firmly positioned for a stronger climb.

Frequently Asked Questions (FAQs)

The analyst noted that past bullish cycles often began with accumulation phases before breakout rallies.

A Head and Shoulders formation on the 4-hour chart is guiding near-term expectations.

The DTA Standard supports tokenization growth, reinforcing Chainlink’s adoption in real-world asset markets.

Bitcoin's recent price spike has raised concerns that the upcoming U.S. government shutdown is driving investors to look for alternative assets.

Institutional money rushed into Solana this week, making the network a standout amid broader outflows in digital-asset funds.

At the same time, the coin’s price has been edging closer to the $250 mark, a key psychological and technical resistance level.

Such momentum has not gone unnoticed, as traders and analysts are watching to see whether Solana can sustain this rally.

The move quickly drew attention across the market, as large-scale inflows like this often reflect growing confidence in future price gains.

Solana Surpasses Ethereum in September Inflows, Boosting Bullish Outlook
$291M Flows Into Solana — Can Price Smash Through $250? Analysts and entrepreneurs note that such inflows are not only substantial in size but also in timing, as the overall crypto market exhibits signs of renewed strength.

Advertisement
 

According to market data, Solana’s share of total institutional inflows now surpasses that of Ethereum for the same period, marking a notable shift in investor preference.

This development adds weight to the argument that Solana is gaining traction as a leading blockchain for scalability and adoption. 

The move quickly drew attention across the market, as such large-scale buys often signal strong confidence in future price gains.

Short-term market context: price and volume
Solana’s spot price traded in the low-$200s on September 29, 2025. CoinGecko reported SOL at roughly $210 on that date, with a seven-day range from about $192 to $222.

CoinMarketCap’s live price on the same day showed SOL around US$210 with a 24-hour trading volume in the billions. These price datapoints provide context: the inflows arrived while SOL was well below its January 2025 all-time high near US$293.

The $291 million inflow into Solana ETPs on Sept. 29, 2025, is a clear, data-backed sign of concentrated institutional interest.  

The proof of a lasting move will be whether demand strengthens the price above the $245–$250 resistance with commensurate volume, and whether the broader market environment sustains risk appetite.

Crypto.com and Sharps Technology, Inc. announced that STSS has expanded its digital asset treasury strategy with Crypto.com services for its holdings.

STSS is an emerging player in digital asset treasury management, with a vision to “align traditional finance with the Solana ecosystem.”

The company has previously announced plans to “establish a Solana-focused digital asset treasury strategy and, to date has acquired more than 2 million SOL.”

As part of this collaboration, STSS intends to use Crypto.com’s platform, including its “institutional-grade custody infrastructure and OTC desk, which offers deep liquidity, competitive pricing, and discreet execution, to manage its digital asset treasury.”

Crypto.com will also integrate several Solana projects, “representing a significant step in expanding access to the Solana ecosystem through qualified custodians.”

This partnership underscores STSS’s commitment “to advancing the growth of the Solana network in close alignment with key Solana ecosystem players.”

The company’s Solana holdings are currently “valued at over $400 million, with SOL trading above $200.”

By deploying a portion of this capital through Crypto.com into Solana-native projects, STSS aims to “generate yield while simultaneously expanding liquidity across the Solana ecosystem.”

Eric Anziani, President and Chief Operating Officer of Crypto.com, said,

“Crypto.com is … built to offer the comprehensive capabilities required by institutions to safely and effectively manage digital asset treasuries.”

James Zhang, Strategic Advisor to STSSsai, said,

“At STSS, we view our digital asset treasury not only as a balance sheet strategy, but as a commitment to advancing the future of open, efficient financial infrastructure. Partnering with Crypto.com, a platform with over 150 million users, provides us with the institutional-grade tools and liquidity access to responsibly manage one of the largest Solana treasuries, while also directly contributing to the growth of the Solana ecosystem. This collaboration marks a pivotal step in aligning our long-term corporate strategy with innovation at the forefront of digital finance.” 

Founded in 2016, Crypto.com claims that it is trusted by users worldwide.

As covered, Crypto.com is committed to accelerating the “adoption of cryptocurrency through innovation and empowering the next generation of builders, creators, and entrepreneurs to develop a fairer and more equitable digital ecosystem.”

Sharps Technology is a medical device and pharmaceutical packaging company offering “patented, best-in-class, smart-safety syringe products to the healthcare industry.”

The company’s product lines focus on “providing waste capabilities that incorporate syringe technologies that use both passive and active safety features.”

The company has adopted a digital asset treasury strategy “focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises to power on chain yield generation with the Solana Ecosystem.”

Decentralized yield protocol Pendle disclosed that an onchain wallet has been drained, and an exploiter is minting principal/yield tokens “to dumping.”